Across the recent three months, 11 analysts have shared their insights on BioNTech (NASDAQ:BNTX), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish |
---|
Total Ratings | 4 | 2 | 4 | 1 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 1 | 2 | 0 | 0 |
2M Ago | 1 | 0 | 1 | 0 | 0 |
3M Ago | 1 | 1 | 1 | 1 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.55, a high estimate of $171.00, and a low estimate of $90.00. This current average has increased by 1.79% from the previous average price target of $110.57.
Deciphering Analyst Ratings: An In-Depth Analysis
In examining recent...
在最近三個月中,11位分析師分享了他們對BioNTech(納斯達克股票代碼:BNTX)的見解,表達了從看漲到看跌的各種觀點。
在下表中,您將找到他們最近的評級摘要,揭示了過去30天中情緒的變化,並將其與...